Physician

Fareeha Hafeez, MD

According to 2025 Medicare claims, Fareeha Hafeez, MD (NPI: 1285981340) practices sleep medicine in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is PULMONARY AND SLEEP ASSOCIATES OF MERCER-BUCKS (NPI: 1023853579; TIN: 993720553) and primary practice location at 08690-1229. Hafeez is affiliated with the WellSpan Population Health Services (ACO ID: A2500) and Capital Health Accountable Care Organization, LLC (ACO ID: A2528), participating under the MSSP model.

Hafeez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 120 traditional Medicare patients, billed 235 HCPCS/CPT codes, and received $16,604 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 542 prescription claims across 106 beneficiaries totaling $147,095 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 776 claims. Open Payments data shows 2 records totaling $103. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $44,230 to $16,604. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $22,085 and ending at $147,095. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $767 and ending at $39,436.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$83K$167K2017 Medicare payment: $44,230 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $166,818 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $61,269 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,769 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,746 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $33,255 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $16,604 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017207519$44,230
20187841,913$166,818
2019411726$61,269
2020N/RN/RN/R
20214758$3,769
20228285$5,746
2023198409$33,255
2024120235$16,604

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$163K$325K2015 Drug cost: $22,085 (USD; Tot_Drug_Cst)2016 Drug cost: $108,159 (USD; Tot_Drug_Cst)2017 Drug cost: $49,984 (USD; Tot_Drug_Cst)2018 Drug cost: $325,424 (USD; Tot_Drug_Cst)2019 Drug cost: $258,982 (USD; Tot_Drug_Cst)2020 Drug cost: $22,018 (USD; Tot_Drug_Cst)2021 Drug cost: $10,958 (USD; Tot_Drug_Cst)2022 Drug cost: $15,845 (USD; Tot_Drug_Cst)2023 Drug cost: $246,162 (USD; Tot_Drug_Cst)2024 Drug cost: $147,095 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201523120$22,085
201643291$108,159
201788254$49,984
20182151,167$325,424
2019144670$258,982
20202337$22,018
20211637$10,958
20222663$15,845
2023119511$246,162
2024106542$147,095

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$27K$54K2016 Medicare payment: $342 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,491 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $51,458 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $53,555 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $9,094 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $4,031 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $5,657 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $17,246 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $28,857 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R12$342
20171170$1,491
2018310889$51,458
20192901,224$53,555
202051303$9,094
202141142$4,031
202266232$5,657
2023168395$17,246
2024244776$28,857

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more2727$104
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1427$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more71105$63
94060Test to measure expiratory airflow and volume changes before and after medication administration1111$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter411,545$32,358
Breo ElliptaFluticasone/Vilanterol532,130$27,324
Breztri AerosphereBudesonide/Glycopyr/Formoterol23750$15,611
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15750$10,740
Incruse ElliptaUmeclidinium Bromide14480$5,288

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0601Continuous positive airway pressure (cpap) deviceY24150$4,369
A7030Full face mask used with positive airway pressure device, eachN2552$4,249
A7031Face mask interface, replacement for full face mask, eachN2145$3,931
E0470Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)YN/R35$2,978
A4604Tubing with integrated heating element for use with positive airway pressure deviceN3273$2,582

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$103AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Fareeha Hafeez, MD?

Tedicare shows public-source Medicare data for Fareeha Hafeez, MD (NPI 1285981340), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fareeha Hafeez, MD have ACO affiliation data?

Fareeha Hafeez, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500) and Capital Health Accountable Care Organization, LLC (MSSP, ACO ID A2528).

What billing organization is linked to Fareeha Hafeez, MD?

Fareeha Hafeez, MD is linked to PULMONARY AND SLEEP ASSOCIATES OF MERCER-BUCKS (billing NPI 1023853579) in the available physician profile data.

Does Fareeha Hafeez, MD have Open Payments data?

Fareeha Hafeez, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.